B Lynne Parshall sold $274K of Cytokinetics stock
By AlphaYouPublished Form 4
PARSHALL B LYNNE
Reporting filer
B Lynne Parshall reported selling 5,000 shares of Cytokinetics Inc for about $274K ($54.73 a share on average). Form 4 filed Nov 12, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | PARSHALL B LYNNE | 2026-11-09 | S | Sale | 2445 | 54.17 | 8,339 | 3 days | Filed terms
|
| Common Stock | PARSHALL B LYNNE | 2026-11-09 | S | Sale | 2555 | 55.26 | 5,784 | 3 days | Filed terms
|
Common Stock
- Owner
- PARSHALL B LYNNE
- Date
- 2026-11-09
- Code
- S
- Action
- Sale
- Quantity
- 2445
- Price
- 54.17
- Following holdings
- 8,339
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 2445
- transaction Price Per Share: 54.17
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 8339
- direct Or Indirect Ownership: D
Common Stock
- Owner
- PARSHALL B LYNNE
- Date
- 2026-11-09
- Code
- S
- Action
- Sale
- Quantity
- 2555
- Price
- 55.26
- Following holdings
- 5,784
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 2555
- transaction Price Per Share: 55.26
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 5784
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- PARSHALL B LYNNE: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The reported transaction involves sale transactions from $53.72 to $54.69 per share. The weighted average price per share was $54.17. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
- F2: The reported transaction involves sale transactions from $54.78 to $55.71 per share. The weighted average price per share was $55.26. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
Original sources
Prepared automatically from public filing data. Report a correction.